However, the present study revealed that Tat‐SIRT5‐CTM targets the SIRT5‐ANXA1 complex, resulting in SIRT5 degradation via the lysosomal pathway, which eventually alleviates microglia‐induced neuroinflammation and neuronal injury following ischemic stroke.20 This evidence concerns the gene SIRT5 and ischemic stroke.